Literature DB >> 22908536

Enamel matrix derivative and transforming growth factor-beta1 in Class III furcation defects. A histomorphometric study in dogs.

Daniela B Palioto1, Guilherme de O Macedo, Adriana C Queiroz, Mário Taba, Sérgio L S Souza, Márcio F M Grisi, Arthur B Novaes.   

Abstract

The objective of this study was to evaluate histomorphometrically, in dogs, the effect of enamel matrix derivative (EMD), with or without transforming growth factor-beta1 (TGF-beta1), in a periodontal Class III furcation model. Class III furcation defects were created in P3 and P4 of six dogs. The defects were allowed to stabilize for 21 days. Four experimental conditions were established: G1: control (propylene glycol alginate); G2: EMD; G3: TGF-beta1 and G4: EMD + TGF-beta1. After 12 weeks, the dogs were euthanized. Their jaws were removed, fixed, decalcified, dehydrated and embedded in paraffin. Semi-serial sections were obtained, stained and examined with light microscopy. The furcation defects were not completely closed in any specimen, with downgrowth of the junctional epithelium into the furcation area. The morphologic characteristics of the newly formed tissues in the test groups were similar to the control group, with slight differences in average values, but with no statistically significant differences between the groups. This study was not able to provide histological evidence that EMD, TGF-beta1 and EMD + TGF-beta1 present additional advantages in periodontal bone formation in a Class III furcation model in dogs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22908536

Source DB:  PubMed          Journal:  J Int Acad Periodontol        ISSN: 1466-2094


  1 in total

1.  The efficiency of using enamel matrix derivative in therapeutic approach of periodontal furcation defects of maxillary and mandibular molars.

Authors:  Anca Silvia Dumitriu; Andreea Cristiana Didilescu; Marina Cristina Giurgiu; Ştefan Dimitrie Albu; Cristiana Elena Pădure; Ximena Anca Nicolae; Stana Păunică
Journal:  Rom J Morphol Embryol       Date:  2021 Apr-Jun       Impact factor: 1.033

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.